Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Alesta Therapeutics B.V.
June 25, 2026
Alesta Therapeutics B.V.
Orphan Drug Designation
treatment of perinatal/infantile-onset and juvenile-onset hypophosphatasia
Disease Area:
Rare Diseases
Source
Scroll to Top
